• SENSEX 77,250.10
    332.25 (+0.43%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,824.90 1,878.00(%)
  • Bharti Airtel
    2,042.90 1,726.05(%)
  • Reliance Industries
    1,315.50 1,611.20(%)
  • SBI Life Insuran
    1,706.80 2,132.90(%)
  • Saregama India
    647.20 574.85(%)
  • Multi Comm. Exc.
    3,252.50 1,761.43(%)
  • Aster DM Quality
    710.25 890.95(%)
  • Shree Cement
    24,342.85 28,306.45(%)
  • Jio Platforms
    1,420.50 1,356.40(%)
  • SFC Enviro.
    397.60 354.05(%)
  • Global Health
    1,422.10 1,542.00(%)
  • HDFC Bank
    741.00 1,017.90(%)
  • BLS Polymers
    261.80 225.00(%)
  • J K Cements
    5,155.30 6,363.00(%)
  • Info Edg.(India)
    1,159.40 909.20(%)
  • ITC
    283.50 421.70(%)
  • SBI
    987.75 1,234.80(%)
  • M & M
    2,942.00 3,840.00(%)
  • Fractal Analyt.
    839.45 1,119.60(%)
  • TBO Tek
    1,522.00 1,005.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Brooks Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 40505.0
  • ISIN : INE650L01011
64.56 1 (1.73%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    63.59

  • Today’s High

    67.63

  • Open

    63.59

  • Perv Close

    63.46

  • 52W Low

    36.30

  • 52W High

    113.69

Key Indicators

  • P/E(TTM)

    41.73

  • Mar.Cap (₹Cr.)

    190.18

  • Div & Yield %

    0.00

  • Book Value(₹)

    41.02

  • Debt-Equity Ratio

    1.73

  • AGM Date

    03-Nov-2026

  • EPS

    1.55

  • P/E Ratio

    41.73

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    190.18

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    29.46

  • BV (₹)

    41.00

  • Sales( ₹ in Cr.)

    85.74

  • NP (in Cr.)

    5.52

  • NP Var(%)

    82.0

  • Div%

    0.0

  • CPS (₹)

    2.40

  • EPS (₹)

    1.90

  • Traded Value (₹ in Lakhs)

    190.53

  • 52 Week High

    113.69

  • 52 Week Low

    36.30

  • Price BSE

    65.0

  • Price NSE

    65.00

  • Market Capital( in Cr.)

    190.53

  • P/C Ratio

    26.90

  • P/E Ratio

    34.70

  • Price Vs.BV

    1.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 85.74 82.56 79.49 55.54 76.97 77.27
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 85.74 82.56 79.49 55.54 76.97 77.27
Other Income 1.17 0.88 0.92 0.12 0.95 0.96
Stock Adjustments 0.84 0.15 -1.40 -2.01 2.93 3.34
Total Income 87.75 83.59 79.01 53.65 80.85 81.57
EXPENDITURE :            
Raw Materials 53.19 55.60 56.59 39.48 53.59 52.56
Power and Fuel Cost 2.23 1.88 1.73 1.58 1.64 2.70
Employee Cost 14.62 12.45 10.09 10.65 10.88 12.04
Other Manufacturing Expenses 2.36 2.02 1.34 1.22 3.77 3.17
Selling and Administration Expenses 5.83 4.91 4.05 4.91 6.39 6.57
Miscellaneous Expenses 1.28 0.87 1.03 1.50 1.75 2.63
Employee Benefit Expenses 14.62 12.45 10.09 10.65 10.88 12.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 79.52 77.73 74.83 59.34 78.02 79.67
Operating Profit 8.23 5.86 4.17 -5.70 2.82 1.91
Interest 0.84 1.03 0.84 0.77 0.67 3.25
Gross Profit 7.39 4.83 3.33 -6.47 2.15 -1.34
Depreciation 1.59 1.60 1.77 1.72 1.49 7.09
Profit Before Tax 5.80 3.23 1.56 -8.19 0.66 -8.43
Current Tax 0.00 0.18 0.03 0.00 0.00 7.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 5.81 3.05 1.53 -8.18 0.67 -15.59
Extraordinary Items 0.29 0.02 0.01 0.01 0.26 -0.06
Adjusted Net Profit 5.52 3.03 1.52 -8.19 0.41 -15.53
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -18.73
P & L Balance brought forward -31.72 -34.78 -36.30 -28.12 -28.79 5.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -25.92 -31.72 -34.78 -36.30 -28.12 -28.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.97 1.04 0.58 -3.31 0.27 -6.31
Earnings Per Share(Adj)-Unit Curr 1.97 1.04 0.58 -3.28 0.27 -6.25
Book Value 41.02 39.06 26.49 22.98 26.31 25.99
Book Value(Adj)-Unit Curr 41.02 39.06 26.49 22.76 26.06 25.74

Shareholding Pattern

  • Promoter Group

    52.62%

  • Public Share Holding

    47.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 15,500,292 52.62 15,500,292 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,500,292 52.62 15,500,292 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 12,098 0.04 12,098 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,916,111 9.90 2,916,111 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 177,698 0.60 177,698 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,105,907 10.54 3,105,907 5
2] Non Institution
Bodies Corporate 978,708 3.32 978,708 63
Clearing Members 68,022 0.23 68,022 15
Directors of their Relatives 100 0.00 100 1
Employees 1,865 0.01 537 7
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 276,201 0.94 276,201 146
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 408,100 1.39 408,100 251
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,622,523 12.30 3,622,523 65
Individuals holding nominal share capital up to Rs. 1 lakh 5,455,769 18.52 5,455,397 10,683
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 10 0.00 10 1
Sub Total 10,851,049 36.84 10,849,349 11,240
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 29,457,248 100.00 29,455,548 11,253

Company Background

Brooks Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Brooks Laboratories Ltd
  • BSE Code : 40505.0
  • ISIN : INE650L01011

  • Incorporation Year

    2002

  • Registered Office

    Village Kishanpura
    Nilagarh Road Baddi, Solan,
    Himachal Pradesh-174101

  • Telephone

    91-1795-654001/02/03

  • FAX

    91-1795-236939

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    DMKH & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Brooks Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Brooks Lab. 64.68 86.91 85.74 41.73 4.25
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77